NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK (FEMALE CONTRACEPTIVE CLINICAL TRIAL TOPIC AREA) RELEASE DATE: November 20, 2002 NOTICE: NOT-HD-03-002 National Institute of Child Health and Human Development (NICHD) (http://www.nichd.nih.gov/) RFP AVAILABLE: RFP-NICHD-2003-04 The National Institute of Child Health and Human Development (NICHD) is planning to issue an RFP for multiple Indefinite-Quantity, Indefinite- Delivery (IDIQ) Task Order contracts for the NICHD Contraceptive Clinical Trials Network (Female Contraceptive Clinical Trial Topic Area). The NICHD is the lead Federal agency for the conduct of basic, clinical, and epidemiological research to develop new contraceptives and to evaluate existing methods of contraception. The Center for Population Research (CPR), NICHD, was established in 1968 by the Secretary of Health, Education and Welfare, with the important goal of developing new contraceptives through the use of contracts and grants. Within CPR, the Contraception and Reproductive Health Branch (CRHB) has long supported several pre-clinical contraceptive testing facilities, as well as facilities for chemical and peptide synthesis. To further expand their contraceptive development capabilities, in 1996 CRHB established the initial NICHD Contraceptive Clinical Trials Network (CCTN) in order to conduct Phase I, II, and III clinical trials of new female contraceptive methods. The NICHD CCTN is an important component of the CRHB contraceptive development capability. Products that have undergone synthesis and successful pre-clinical testing, either through the CRHB formulation and testing facilities or through outside sources, are candidates for clinical testing in the CCTN. The CCTN is particularly valuable for providing a venue for testing new contraceptive drugs and devices that have been developed by small companies that lack the resources to support large-scale Phase I, II, and III clinical trials of new female contraceptive methods. The new CCTN, operating under Indefinite-Quantity, Indefinite-Delivery (IDIQ) Task Order contracts, will be able to rapidly develop protocols and initiate clinical trials shortly after candidate products have completed the necessary pre-clinical testing. The resultant IDIQ contracts will consist of a one- year base period and six one-year option periods. Both female and male contraceptives will undergo Phase I, II, and III clinical trials in the new CCTN. It is estimated that the new CCTN will consist of approximately 12 sites capable of performing female contraceptive clinical trials and approximately four sites capable of performing male contraceptive clinical trials. Please be advised that the NICHD is issuing separate RFPs for each topic area (i.e., Female Contraceptive Clinical Trials and Male Contraceptive Clinical Trials) in order to better facilitate and coordinate the evaluation of proposals. This announcement is for the RFP for the Female Contraceptive Trials Topic Area, only. Offerors may choose to propose in response to either RFP (Female Contraceptive Trials or Male Contraceptive Trials) or to both RFPs, depending on their organization's capabilities. However, please be advised that the NICHD will not accept combined proposals (Female and Male) from offerors who wish to propose in response to both RFPs. Those offerors who propose in response to both RFPs must provide separate individual Technical and Business Proposals in response to each RFP. Organizations that believe they have the capabilities and recruitment ability necessary to participate in this network may access the Request for Proposal(s), RFP-NICHD-2003-04, electronically on the FedBizOpps website, at http://www2.eps.gov/servlet/Solicitation/R/HHS/NIH/NICHD/RFP-NICHD-2003-05, on or about November 1, 2002. Please note that the NICHD does not intend to release hard copies of the RFP. The NICHD also reserves the right to cancel the requirement at any time prior to contract award. INQUIRIES Charles Newman Contracting Officer Contracts Management Branch National Institute of Child Health and Human Development 6100 Executive Boulevard, Suite 7A07, MSC 7510 Bethesda, MD 20892-7510 Telephone: 301-435-6960 Fax: 301-402-3676 Email: cn43m@nih.gov OR Charles Grewe Deputy Chief Contracting Officer Contracts Management Branch National Institute of Child Health and Human Development 6100 Executive Boulevard, Suite 7A07, MSC 7510 Bethesda, MD 20892-7510 Telephone: 301-435-6957 Fax: 301-402-3676 Email: cg59b@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices


H H S Department of Health
and Human Services

 
  N I H National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892